AREGALU õhukese polümeerikattega tablett Eistland - eistneska - Ravimiamet

aregalu õhukese polümeerikattega tablett

krka, d.d., novo mesto - teriflunomiid - õhukese polümeerikattega tablett - 14mg 84tk; 14mg 14tk; 14mg 98tk; 14mg 28tk; 14mg 30tk

Teriflunomide Accord Evrópusambandið - eistneska - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosuppressants, valikuline immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

BOXARID õhukese polümeerikattega tablett Eistland - eistneska - Ravimiamet

boxarid õhukese polümeerikattega tablett

gedeon richter plc. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 28tk; 14mg 14tk; 14mg 98tk; 14mg 84tk

MELITERIX õhukese polümeerikattega tablett Eistland - eistneska - Ravimiamet

meliterix õhukese polümeerikattega tablett

norameda uab - teriflunomiid - õhukese polümeerikattega tablett - 14mg 28tk

TIFAY õhukese polümeerikattega tablett Eistland - eistneska - Ravimiamet

tifay õhukese polümeerikattega tablett

stada arzneimittel ag - teriflunomiid - õhukese polümeerikattega tablett - 14mg 28tk; 14mg 84tk

TEREBYO õhukese polümeerikattega tablett Eistland - eistneska - Ravimiamet

terebyo õhukese polümeerikattega tablett

sandoz pharmaceuticals d.d. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 84tk; 14mg 28tk

Teriflunomide Mylan Evrópusambandið - eistneska - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosupressandid - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

TERIFLUNOMIDE ZENTIVA õhukese polümeerikattega tablett Eistland - eistneska - Ravimiamet

teriflunomide zentiva õhukese polümeerikattega tablett

zentiva k.s. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 14tk; 14mg 28tk; 14mg 84tk

TERIFLUNOMIDE TEVA õhukese polümeerikattega tablett Eistland - eistneska - Ravimiamet

teriflunomide teva õhukese polümeerikattega tablett

teva b.v. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 14tk; 14mg 28tk; 14mg 30tk; 14mg 84tk

METEX süstelahus süstlis Eistland - eistneska - Ravimiamet

metex süstelahus süstlis

medac gesellschaft für klinische spezialpräparate mbh - metotreksaat - süstelahus süstlis - 50mg 1ml 0.25ml 6tk; 50mg 1ml 0.6ml 12tk; 50mg 1ml 0.45ml 24tk; 50mg 1ml 0.15ml 10tk; 50mg 1ml 0.3ml 1tk; 50mg 1ml 0.2ml 5tk; 50mg 1ml 0.2ml 12tk; 50mg 1ml 0.4ml 24tk; 50mg 1ml 0.5ml 5tk; 50mg 1ml 0.4ml 10tk; 50mg 1ml 0.2ml 6tk; 50mg 1ml 0.3ml 11tk; 50mg 1ml 0.15ml 24tk; 50mg 1ml 0.3ml 24tk; 50mg 1ml 0.6ml 4tk; 50mg 1ml 0.55ml 12tk; 50mg 1ml 0.5ml 1tk; 50mg 1ml 0.4ml 4tk; 50mg 1ml 0.5ml 12tk; 50mg 1ml 0.5ml 10tk; 50mg 1ml 0.25ml 4tk; 50mg 1ml 0.5ml 6tk; 50mg 1ml 0.55ml 4tk; 50mg 1ml 0.45ml 4tk; 50mg 1ml 0.6ml 1tk; 50mg 1ml 0.55ml 24tk; 50mg 1ml 0.4ml 5tk; 50mg 1ml 0.55ml 1tk; 50mg 1ml 0.25ml 10tk; 50mg 1ml 0.2ml 10tk; 50mg 1ml 0.45ml 1tk; 50mg 1ml 0.45ml 5tk; 50mg 1ml 0.5ml 24tk; 50mg 1ml 0.25ml 11tk; 50mg 1ml 0.45ml 10tk; 50mg 1ml 0.5ml 4tk; 50mg 1ml 0.25ml 5tk; 50mg 1ml 0.55ml 10tk; 50mg 1ml 0.45ml 12tk; 50mg 1ml 0.15ml 12tk; 50mg 1ml 0.25ml 24tk; 50mg 1ml 0.35ml 6tk; 50mg 1ml 0.4ml 11tk; 50mg 1ml 0.45ml 6tk; 50mg 1ml 0.35ml 10tk; 50mg 1ml 0.2ml 24tk; 50mg 1ml 0.2ml 1tk; 50mg 1ml 0.3ml 6tk; 50mg 1ml 0.6ml 5